Journal of Clinical Epidemiology
Volume 52, Issue 3 , Pages 187-192 , March 1999

Generic and Specific Measurement of Health-Related Quality of Life in a Clinical Trial of Respiratory Rehabilitation

  • Gordon H. Guyatt

      Affiliations

    • Dr. Guyatt is a Career Scientist of the Ontario Ministry of Health.
    • Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada
    • Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    • Corresponding Author InformationAddress correspondence to: Dr. G. Guyatt, Room 2C12, McMaster University Health Sciences Centre, 1200 Main Street West, Hamilton, Ontario, Canada, L8N 3Z5
    • ,
  • Derek R. King

      Affiliations

    • Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada
    • ,
  • David H. Feeny

      Affiliations

    • Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada
    • Centre for Health Economic and Policy Analysis, McMaster University, Hamilton, Ontario, Canada
    • ,
  • David Stubbing

      Affiliations

    • Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    • ,
  • Roger S. Goldstein

      Affiliations

    • Department of Medicine, University of Toronto, Toronto, Ontario, Canada

,Accepted 6 November 1998.

References 

  1. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life (Basic Sciences Review). Ann Intern Med. 1993;70:225–230
  2. Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care. 1989;27:F217–F232
  3. Liang MH, Larson MG, Cullen KE, Schwartz JA. Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research. Arthritis Rheum. 1985;28:542–547
  4. Lacasse Y, Goldstein RS, Wong E, Guyatt GH, King K, Cook DJ. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. Lancet. 1996;348:1115–1119
  5. Goldstein RS, Gort EH, Guyatt GH, Stubbing D, Avendano MA. Prospective randomized controlled trial of respiratory rehabilitation. Lancet. 1994;344:1394–1397
  6. McGavin CR, Artvinli M, Naoe H, McHardy GJR. Dyspnoea, disability, and distance walked (Comparison of estimates of exercise performance in respiratory disease). BMJ. 1978;2:241–243
  7. Bergner M, Bobbit RA, Carter WB, Gilson BS. The Sickness Impact Profile (Development and final revision of a health status measure). Med Care. 1981;19:787–805
  8. Torrance GW. Measurement of health state utilities for economic appraisal. J Health Econ. 1986;5:1–30
  9. Kaplan RM, Bush JW. Health-related quality of life measurement for evaluation research and policy analysis. Health Psychol. 1982;1:61–80
  10. Kaplan RM, Bush JW, Berry CC. Health status (Types of validity and the index of well-being). Health Serv Res. 1976;11:478–507
  11. Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987;42:773–778
  12. Guyatt GH, Townsend M, Keller J, Singer J, Nogradi S. Measuring functional status in chronic lung disease (Conclusions from a randomized control trial). Respir Med. 1989;83:293–297
  13. Wijkstra PJ, TenVergert EM, Van Altena R, Otten V, Postma DS, Kraan J, et al.  Reliability and validity of the chronic respiratory questionnaire (CRQ). Thorax. 1994;49:465–467
  14. Mahler DA, Weinberg DH, Wells CK, Feinstein AR. The Measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest. 1984;85:751–758
  15. Mahler DA, Matthay RA, Snyder PE, et al.  Sustained-release theophylline reduces dyspnea in nonreversible obstructive airway disease. Am Rev Respir Dis. 1985;131:22–25
  16. Butland RJA, Pang J, Gross ER, Woodcock AA, Geddes D. Two-, six-, and twelve-minute walking tests in respiratory disease. BMJ. 1982;284:1607–1608
  17. Guyatt GH, Pugsley S, Sullivan M, Thompson PJ, Berman L, Jones NL, et al.  Effect of encouragement on walking test performance. Thorax. 1984;39:818–822
  18. Tandon PK, Stander H, Schwarz RP. Analysis of quality of life data from a randomized, placebo controlled heart-failure trial. J Clin Epidemiol. 1989;42:955–962
  19. Smith D, Baker G, Davies G, Dewey M, Chadwick DW. Outcomes of add-on treatment with Lamotrigine in partial epilepsy. Epilepsia. 1993;34:312–322
  20. Change SW, Fine R, Siegel D, Chesney M, Black D, Hulley SB. The impact of diuretic therapy on reported sexual function. Arch Intern Med. 1991;151:2402–2408
  21. Tugwell P, Bombardier C, Buchanan WW, Goldsmith C, Grace E, Bennett KJ, et al.  Methotrexate in rheumatoid arthritis. Impact on quality of life assessed by traditional standard-item and individualized patient preference health status questionnaires. Arch Intern Med. 1990;150:59–62
  22. Laupacis A, Wong C, Churchill D. The use of generic and specific quality-of-life measures in hemodialysis patients treated with erythropoietin. Control Clin Trials. 1991;12:168S–179S
  23. Bombardier C, Ware J, Russell IJ, Larson M, Chalmers A, Read JL. Auranofin therapy and quality of life in patients with rheumatoid arthritis. Am J Med. 1986;81:565–578
  24. Regensteiner JG, Meyer TJ, Krupski WC, Cranford LS, Hiatt WR. Hospital vs home-based exercise rehabilitation for patients with peripheral arterial occlusive disease. Angiology. 1997;48:291–300
  25. Watson RG, Tham TC, Johnston BT, McDougall NI. Double blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux—the “sensitive oesophagus.”. Gut. 1997;40:587–590
  26. Regensteiner JG, Steiner JF, Hiatt WR. Exercise training improves functional status in patients with peripheral arterial disease. J Vasc Surg. 1996;23:104–115
  27. Stenstrom CH, Arge B, Sundbom A. Dynamic training versus relaxation training as home exercise for patients with inflammatory rheumatic diseases. A randomized controlled study. Scand J Rheumatol. 1996;25:28–33
  28. Boline PD, Kassak K, Bronfort G, Nelson C, Anderson AV. Spinal manipulation vs. amitriptyline for the treatment of chronic tension-type headaches (A randomized clinical trial). J Manipulative Physiol Ther. 1995;18:148–154
  29. Guidelines for Economic Evaluation of Pharmaceuticals: Canada, 1st Edition. Canadian Coordinating Office for Health Technology Assessment. Ottawa: Canadian Coordinating Office for Health Technology Assessment; November, 1994.

PII: S0895-4356(98)00157-7

Journal of Clinical Epidemiology
Volume 52, Issue 3 , Pages 187-192 , March 1999

Article Tools